stocks3 months ago
Taysha Gene Therapies stock rises on Rett syndrome trial data
Investing.com
stocks
The latest stocks headlines, updated continuously. · Page 321
stocks3 months ago
BitFuFu stock rises on $5 million buyback program
Investing.com
stocks3 months ago
Nuvectis Pharma stock rises on Haisco licensing deal
Investing.com
stocks3 months ago
US FDA reverses course on Regenxbio’s rare-disease gene therapy, backs accelerated approval bid
Investing.com
stocks3 months ago
Amazon Prime Day expected to drive $26.3 billion in online sales
Investing.com
stocks3 months ago
Why is Chevron stock climbing today?
Investing.com
stocks3 months ago
Palvella stock rises on FDA rolling review for rare disease drug
Investing.com
stocks3 months ago
Buy gold stocks as valuations are cheap amid macro tension: BofA
Investing.com
stocks3 months ago
Praxis Precision Medicines stock rises on FDA breakthrough status
Investing.com
stocks3 months ago
Cleveland-Cliffs stock falls after Morgan Stanley downgrade
Investing.com
stocks3 months ago
Why is Ecarx stock gaining today?
Investing.com
stocks3 months ago
Fervo Energy stock surges on geothermal digital twin project
Investing.com
stocks3 months ago
Miner Sinda kicks off US IPO roadshow with $1.97 billion valuation target
Investing.com
stocks3 months ago
Factbox-Major deals involving US drugmakers and biotechs over the past decade
Investing.com
stocks3 months ago
Oaktree-backed ITG targets $2.7 billion valuation in US IPO
Investing.com
stocks3 months ago
JPM identifies consumer sectors to buy for a 2H rebound
Investing.com
stocks3 months ago
WiseTech shares tumble on news reports police are investigating founder White
Investing.com
stocks3 months ago
SK Hynix overtakes Samsung to become South Korea’s most valuable company
Investing.com